|
¹Ì±¹ÀÇ Ã¼¿Üµ¶¼º °Ë»ç½ÃÀåÀº 2006³â 7¾ï 6,500¸¸´Þ·¯ ±Ô¸ð¸¦ ±â·ÏÇßÀ¸¸ç ÇâÈÄ ¿¬Æò±Õ 14.4% Áõ°¡ÇÏ¿© 2011³â¿¡´Â 15¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
30³â ÀÌ»ó¿¡ °ÉÃÄ °íǰÁúÀÇ ½ÃÀåÁ¶»çº¸°í¼·Î ½ÇÀûÀ» ½×¾Æ¿Â Àú¸íÇÑ ¹Ì±¹ÀÇ Á¶»çȸ»ç BCC Research(º»»ç : ÄÚ³×Æ¼ÄÆ)°¡ ü¿Üµ¶¼º½ÃÀå¿¡ °üÇÑ Á¶»çº¸°í¼ "The Market for In Vitro Toxicology Testing"¸¦ ¹ßÇàÇß½À´Ï´Ù.
ü¿Üµ¶¼ºÀÇ °³¿ä¿Í ÀÚ·á°ËÁõ, ±â¾÷ÇÁ·ÎÆÄÀϰú ÇÔ²² ±â¼úº°, ºÐ¾ßº° ¼öÀÍÀü¸Á°ú µ¿Çâ, ±ÔÁ¦¿Í ƯÇãºÐ¼®, ½ÃÀå °æÀﵿÇâ°ú ÇÔ²² ´ÙÀ½°ú °°ÀÌ ÀüÇØµå¸³´Ï´Ù.
3. °³¿ä
3-2 ü¿Üµ¶¼ºÀÇ °³¿ä
- °³¿ä
- µ¶¼ºÇÐÀÇ °³¿ä
- µ¶¼ºÇÐÀÇ ±âº»¿ø¸®
- µ¶¼ºÇп¡ ÀÌ¿ëµÇ´Â ¾àÁ¦¿Í ºÐ·ù
- ¹°ÁúÀÇ µ¶¼º¿¡ ¿µÇâÀ» ÁÖ´Â ¿äÀÎ
- µ¶¼ºÇÐÀÇ ¹ßÀü
3-5 ±â¼ú°³¿ä
- µ¶¼º°Ë»çÀü·«
- µ¶¼ºÇÐÀÇ Á¾·ù : °Ë»çÀü·«
- ´Ù¾çÇÑ Ä«Å×°í¸®¸¦ À§ÇÑ ´ëüµ¶¼º °Ë»ç¹ý
4. ÀÚ·á°ËÁõ
4-2 ÀÚ·á°ËÁõÀÌ Á÷¸éÇÏ´Â °úÁ¦
- µ¥ÀÌÅÍ »ý¼ºÀÇ À±¸®Àû °£·«È¿Í ÀÔ¼ö¼º
- °Ë»ç¹æ¹ý¿¡ °üÇÑ °¡ÀÌ´ø½ºÀÇ ºÎÁ·
- ÀÚ·á°ËÁõÀ» À§ÇÑ »õ·Î¿î °Ë»ç¹æ¹ýÀÇ ºÒÈ®½Ç¼º
5. ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Accelrys Software, Inc.
- Bio-Rad Laboratories
- Bioreliance Invitrogen bioservices
- Ceetox, Inc.
- Covance, Inc.
- Genego, Inc.
- Gene Logic, Inc.
- HTG, Arizona
- Iconix Biosciences, Inc.
- In vitro International
- In vitro Technologies
- Mattek Corporation
- Molecular Toxicology, Inc.
- Tecan Group AG
- Xenobiotic Detection Systems
- Xenometrix
8. ƯÇ㠺м®
8-1 µ¶¼º ½ºÅ©¸®´×¿¡ °üÇÑ Æ¯Çã °³¿ä
9. ¾÷°èÀÇ °æÀï
9-1 ü¿Üµ¶¼º°Ë»çÀÇ ¾÷°è µ¿Çâ
- ¼·Ð
- ½ÃÀå°³¿ä
- ¾÷°è±¸Á¶
- °æÇÕ±¸Á¶
10. ü¿Üµ¶¼º°Ë»çÀÇ ¾÷°èºÎºÐº° ½ÃÀ嵿Çâ
10-1 ÄÚ½º¸Þƽ ¹× °¡Á¤¿ëǰ
11. ¾÷°è¿ëµµº° ½ÃÀå : ¼öÀÍ¿¹Ãø
12. ±ÔÁ¦°³¿ä
12-4 µ¶¼º°Ë»ç¹ý¿¡ ¿µÇâÀ» ÁÖ´Â ±â°ü
cyj
|